IRIS
FARGNOLI, MARIA CONCETTA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 16.420
AS - Asia 8.517
EU - Europa 8.005
SA - Sud America 1.044
AF - Africa 131
Continente sconosciuto - Info sul continente non disponibili 21
OC - Oceania 16
Totale 34.154
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 16.185
SG - Singapore 3.646
IE - Irlanda 1.839
RU - Federazione Russa 1.799
CN - Cina 1.708
HK - Hong Kong 895
BR - Brasile 875
TR - Turchia 875
SE - Svezia 811
VN - Vietnam 784
DE - Germania 752
IT - Italia 624
GB - Regno Unito 570
UA - Ucraina 489
FR - Francia 373
FI - Finlandia 345
IN - India 134
BD - Bangladesh 133
CA - Canada 124
NL - Olanda 76
JP - Giappone 71
MX - Messico 67
ES - Italia 66
AR - Argentina 59
CZ - Repubblica Ceca 50
PL - Polonia 45
BE - Belgio 44
ZA - Sudafrica 44
IQ - Iraq 36
ID - Indonesia 27
LT - Lituania 27
PK - Pakistan 25
MA - Marocco 23
CO - Colombia 22
EC - Ecuador 21
AT - Austria 19
EU - Europa 18
KR - Corea 18
UZ - Uzbekistan 18
KE - Kenya 17
PE - Perù 16
JO - Giordania 15
VE - Venezuela 15
AU - Australia 14
MY - Malesia 14
CL - Cile 13
IL - Israele 13
AZ - Azerbaigian 11
SA - Arabia Saudita 11
PY - Paraguay 10
RO - Romania 10
TN - Tunisia 10
TW - Taiwan 10
HN - Honduras 9
PH - Filippine 9
UY - Uruguay 9
CR - Costa Rica 8
HU - Ungheria 8
TH - Thailandia 8
AE - Emirati Arabi Uniti 7
BY - Bielorussia 7
DZ - Algeria 7
EG - Egitto 7
LB - Libano 7
NP - Nepal 7
JM - Giamaica 6
KZ - Kazakistan 6
RS - Serbia 6
TT - Trinidad e Tobago 6
AL - Albania 5
CH - Svizzera 5
GE - Georgia 5
KG - Kirghizistan 5
SN - Senegal 5
DK - Danimarca 4
LU - Lussemburgo 4
OM - Oman 4
SK - Slovacchia (Repubblica Slovacca) 4
EE - Estonia 3
KH - Cambogia 3
MD - Moldavia 3
MK - Macedonia 3
PA - Panama 3
AO - Angola 2
BA - Bosnia-Erzegovina 2
BB - Barbados 2
BO - Bolivia 2
CY - Cipro 2
GM - Gambi 2
GR - Grecia 2
GT - Guatemala 2
LC - Santa Lucia 2
ME - Montenegro 2
MN - Mongolia 2
NO - Norvegia 2
XK - ???statistics.table.value.countryCode.XK??? 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AD - Andorra 1
BF - Burkina Faso 1
BG - Bulgaria 1
Totale 34.119
Salva come PNG Salva come JPEG
Città #
Singapore 2.088
Chandler 1.944
Jacksonville 1.919
Dublin 1.835
San Jose 1.727
Dallas 1.607
Hong Kong 878
Ashburn 863
Santa Clara 824
Council Bluffs 737
Boardman 692
The Dalles 491
Izmir 425
New York 390
Moscow 353
Nanjing 338
Princeton 307
Lawrence 306
San Mateo 304
Wilmington 297
Ho Chi Minh City 248
Lauterbourg 212
Beijing 198
Hanoi 185
Los Angeles 182
Ann Arbor 156
Milan 134
Munich 123
Woodbridge 114
Nanchang 108
Columbus 103
São Paulo 98
Hefei 97
Des Moines 90
Mountain View 80
Seattle 74
Shenyang 73
Orem 71
Helsinki 66
Tokyo 64
Rome 58
Lappeenranta 57
Tianjin 57
Amsterdam 56
Hebei 55
Verona 55
Frankfurt am Main 52
L'aquila 50
Falls Church 48
Brooklyn 47
Brno 45
London 44
Brussels 43
Kunming 42
Jiaxing 41
Montreal 41
Jinan 40
Warsaw 40
Stockholm 39
Atlanta 38
Dearborn 37
Shanghai 36
Dong Ket 35
Denver 34
Norwalk 34
Chicago 32
Da Nang 31
San Francisco 31
Boston 30
Changsha 29
Chennai 29
Falkenstein 29
Houston 29
Ningbo 29
Phoenix 29
Turku 28
Belo Horizonte 25
Johannesburg 25
L’Aquila 24
Manchester 24
Nuremberg 24
Mexico City 23
Zhengzhou 23
Guangzhou 22
Haiphong 22
Toronto 22
Brasília 21
Rio de Janeiro 21
Pune 20
Ankara 19
Bremen 18
Fremont 17
Hải Dương 17
Jakarta 17
Mumbai 17
Changchun 16
Nairobi 16
Taizhou 16
Tashkent 16
Hangzhou 15
Totale 22.731
Salva come PNG Salva come JPEG
Nome #
Cutaneous metastatic breast carcinoma: A study of 164 patients 234
Heterogeneity of BRAF, NRAS, and TERT Promoter Mutational Status in Multiple Melanomas and Association with MC1R Genotype: Findings from Molecular and Immunohistochemical Analysis 182
Rapid response of scalp psoriasis to ustekinumab 161
T-cell receptor (TCR) signal transduction: Biochemical mechanisms and possible clinical implications 152
Intra-patient Heterogeneity of BRAF and NRAS Molecular Alterations in Primary Melanoma and Metastases 150
The Alternative TrkAIII Splice Variant, a Targetable Oncogenic Participant in Human Cutaneous Malignant Melanoma 149
Evaluating the role of FAMIly history of cancer and diagnosis of multiple neoplasms in cancer patients receiving PD-1/PD-L1 checkpoint inhibitors: the multicenter FAMI-L1 study 149
Characterization of melanoma susceptibility genes in high-risk patients from Central Italy 148
Staging and follow-up of cutaneous Melanoma patients 146
A variant in FTO shows association with melanoma risk not due to BMI 144
Dermoscopic patterns of acral melanocytic nevi and melanomas in a white population in central Italy 142
Real-life efficacy and safety of ingenol mebutate for the treatment of actinic keratosis of the face and scalp: A single arm retrospective study 137
Short-term effectiveness of guselkumab in psoriatic arthritis patients and axial involvement: results from a real-life multicentre cohort 136
Current psoriasis treatments in an Italian population and their association with socio-demographical and clinical features 136
The oncogenic neurotrophin receptor tropomyosin-related kinase variant, TrkAIII 136
Understanding the molecular genetics of basal cell carcinoma 134
EDNRB gene variants and melanoma risk in two southern European populations. 134
European interdisciplinary guideline on invasive squamous cell carcinoma of the skin: Part 2. Treatment 134
Cutaneous manifestations in Italian kidney transplant recipients 134
A multicenter study of skin toxicity management in patients with left-sided, RAS/BRAF wild-type metastatic colorectal cancer treated with first-line anti-EGFR-based doublet regimen: is there room for improvement? 134
The role of insomnia in the vulnerability to depressive and anxiety symptoms in atopic dermatitis adult patients 133
The first skin cancer screening day at the Italian parliament: a Euromelanoma initiative 133
Exploring the interplay of atopic dermatitis severity with sleep and mental health: a case-control study in adult patients 132
Long-term efficacy and safety of daylight photodynamic therapy with methyl aminolevulinate for actinic keratosis of the face and scalp 131
Early stage melanoma diagnosis and mental health-related: emotional influence of body self-perception 131
MC1R variants predisposing to concomitant primary cutaneous melanoma in a monozygotic twin pair 126
Telomeres and telomerase in cutaneous squamous cell carcinoma 126
MC1R variants increased the risk of sporadic cutaneous melanoma in darker-pigmented Caucasians: a pooled-analysis from the M-SKIP project 125
Contribution of melanocortin-1 receptor gene variants to sporadic cutaneous melanoma risk in a population in central Italy: a case-control study 125
A multicenter study of body mass index in cancer patients treated with anti-PD-1/PD-L1 immune checkpoint inhibitors: When overweight becomes favorable 125
Genetic profiling of a rare condition: co-occurrence of albinism and multiple primary melanoma in a Caucasian family 125
Safe Administration of Ipilimumab, Pembrolizumab, and Nivolumab in a Patient with Metastatic Melanoma, Psoriasis, and a Previous Guillain-Barré Syndrome 124
Melanoma in children and adolescents: analysis of susceptibility genes in 123 Italian patients 124
Diminished TCR signaling in cutaneous T-cell Iymphoma is associated with decreased activities of Zap70, Syk and membrane-associated Csk 123
HLA-C*06:02 Does Not Predispose to Clinical Response Following Long-Term Adalimumab Treatment in Psoriatic Patients: A Retrospective Cohort Study 123
Hypo-epiluminescence microscopy of pigmented skin lesions. A new approach to improve recognition of dermoscopic structures 122
Dermoscopic features of actinic keratosis 122
Parapsoriasi 122
On the interplay of telomeres, nevi and the risk of melanoma 122
Efficacy, tolerability and cosmetic acceptabilily of Toléderm® in patients with inflammatory cutaneous diseases of the face 121
The spectrum of dermatoscopic patterns in blue nevi 121
Pigmented reticular structures in basal cell carcinoma and collision tumours 120
Efficacy evaluation of an oil-in-water emulsion (Dermoflan) in atopic dermatitis 119
Efficacy of treatment with tetracyclines to prevent acneiform eruption secondary to cetuximab therapy 118
Mucosal involvement in a patient with lymphomatoid papulosis 118
Cutaneous and mucosal melanomas of uncommon sites: Where do we stand now? 118
Early Diagnosis of Melanoma and Breast Cancer in Women: Influence of Body Image Perception 117
Frequency of melanocytic nevi in psoriatic patients is related to treatment and not to disease severity 117
Nucleotide diversity and population differentiation of the melanocortin 1 receptor gene, MC1R 117
Identification of four novel melanocortin 1 receptor (MC1R) gene variants in a Mediterranean population 116
Treatments of advanced basal cell carcinoma: a review of the literature 116
Association of Genetic Variants in CDK6 and XRCC1 with the Risk of Dysplastic Nevi in Melanoma-Prone Families 116
Physicians' concerns towards prescription adherence and treatment effectiveness in the clinical management of actinic keratosis 116
Genetic Susceptibility In Familial And Multiple Melanoma Patients In Central Italy 116
Pilotropic mycosis fungoides presenting as an acneiform eruption 116
Biotech on the Rise: The Treatment of Psoriasis with Biological Drugs 116
Clinical experience of imiquimod 3.75% for actinic keratosis: Results from a case series 116
MC1R gene variants and non-melanoma skin cancer: A pooled-analysis from the M-SKIP project 116
Molecular alterations in basal cell carcinoma subtypes 116
The use of chemical peelings in the treatment of different cutaneous hyperpigmentations 115
Basal cell carcinoma and inflammation: role of the Gadd45b gene 115
European consensus-based interdisciplinary guideline for melanoma. Part 2: Treatment – Update 2019 115
MC1R Variants Increase Risk of Melanomas harboring BRAF Mutations 115
MC1R variants increase melanoma risk in families with CDKN2A mutations: a meta-analysis 114
Meta-analysis of risk factors for cutaneous melanoma according to anatomical site and clinico-pathological variant 114
Conventional vs. daylight methyl aminolevulinate photodynamic therapy for actinic keratosis of the face and scalp: An intra-patient, prospective, comparison study in Italy 114
Dermoscopic evolution of a congenital combined nevus in childhood 114
Interferon-beta injection site reactions in patients with multiple sclerosis 114
Operational classification of cutaneous squamous cell carcinomas based on unsupervised clustering of real cases by experts 113
Rare missense variants in POT1 predispose to familial cutaneous malignant melanoma 113
Mycosis fungoides. Clinical and molecular biology observations 113
Risk of second primary malignancies among 1537 melanoma patients and risk of second primary melanoma among 52 354 cancer patients in Northern Italy 113
Management of Cutaneous Squamous Cell Carcinoma of the Scalp in Kidney Transplant Recipients 112
Reduced expression of CDKN2a/p16INK4a in mycosis fungoides 112
A cost-utility analysis of etanercept for the treatment of moderate-to-severe psoriasis in Italy 112
Clinical Trial on Aveeno Skin Relief Moisturizing Lotion in patients with itching accompanied by skin lesions and xerosis 112
Use of recombinant interferon alfa-2b in the treatment of basal cell carcinoma 112
Clinical Outcomes of Patients with Advanced Cancer and Pre-Existing Autoimmune Diseases Treated with Anti-Programmed Death-1 Immunotherapy: A Real-World Transverse Study 112
A 48-week update of a multicentre real-life experience of dupilumab in adult patients with moderate-to-severe atopic dermatitis 112
Dermoscopic features of cutaneous melanoma are associated with clinical characteristics of patients and tumours and with MC1R genotype 111
Dermoscopic variability of basal cell carcinoma according to clinical type and anatomic location 111
Certolizumab pegol for the treatment of psoriatic arthritis and plaque psoriasis 111
Coding and noncoding somatic mutations in candidate genes in basal cell carcinoma 111
Family history of psoriasis and age at disease onset in Italian patients with psoriasis 111
T Cell Immunoglobulin and Mucin Domain 3 (TIM-3) in Cutaneous Melanoma: A Narrative Review 110
Occurrence of multiple melanomas in a patient with punctate palmoplantar keratoderma type-1A associated to alpha and gamma adaptin binding protein 110
Nail and enthesis assessment in patients with psoriatic disease by high frequency ultrasonography: findings from a single-centre cross-sectional study 110
CDKN2A/p16 expression in mycosis fungoides 110
MC1R, SLC45A2 and TYR genetic variants involved in melanoma susceptibility in Southern European populations: Results from a Meta-analysis 110
Impact of COVID-19 Pandemic on Delay of Melanoma Diagnosis: A Systematic Review and Meta-Analysis 109
Use of recombinant interferon alpha-2a in the treatment of squamous cell carcinoma 109
Efficacy and tolerability of 5-aminolevulinic acid 0.5% liposomal spray and intense pulsed light in wrinkle reduction of photodamaged skin 109
Knowledge of melanoma and attitude towards moles in Italian melanoma 109
Multiple microsatellite alterations on chromosome 9 in neurofibromas of NF-1 patients 109
Clinical, dermoscopic, and confocal features of nevi and melanomas in a multiple primary melanoma patient with the MITF p.E318K homozygous mutation 109
Rare bone toxicity associated with vismodegib 109
Comprehensive Evaluation of Allele Frequency Differences of MC1R Variants Across Populations 108
Dermoscopic similarity is an independent predictor of BRAF mutational concordance in multiple melanomas 108
"Your Skin Tells You" Campaign for keratinocyte cancers: when individuals' selection makes the difference 107
Dermatoscopy of basal cell carcinoma: morphologic variability of global and local features and accuracy of diagnosis 107
Totale 12.276
Salva come PNG Salva come JPEG
Categoria #
all - tutte 156.860
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 156.860
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021129 0 0 0 0 0 0 0 0 0 0 0 129
2021/20221.694 96 128 308 108 56 39 23 104 175 17 131 509
2022/20235.428 394 290 94 546 454 608 4 399 2.354 31 173 81
2023/20241.397 210 67 147 204 88 355 42 52 1 64 31 136
2024/20256.230 165 108 590 222 734 573 902 480 1.440 200 450 366
2025/202612.696 540 1.061 1.118 1.346 1.190 783 2.381 613 1.130 1.422 956 156
Totale 34.682